Difference in Gastrointestinal Risk Associated with Use of GLP-1 Receptor Agonists: A Real-World Pharmacovigilance Study

Difference in Gastrointestinal Risk Associated with Use of GLP-1 Receptor Agonists: A Real-World Pharmacovigilance Study

Yu Zhou,1 Mingyu Chen,1 Libin Liu,2 Zhou Chen1 1Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University, Fuzhou, People’s Republic of China; 2Department of Endocrinology, Fujian Medical University Union Hospital, Fuzhou, People’s Republic of ChinaCo...

Full description

Bibliographic Details
Main Authors: Zhou Y, Chen M, Liu L, Chen Z
Format: Article
Language:English
Published: Dove Medical Press 2022-01-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
glp-1 receptor agonists
gastrointestinal adverse drug reactions
pharmacovigilance database
Online Access:https://www.dovepress.com/difference-in-gastrointestinal-risk-associated-with-use-of-glp-1-recep-peer-reviewed-fulltext-article-DMSO

Internet

https://www.dovepress.com/difference-in-gastrointestinal-risk-associated-with-use-of-glp-1-recep-peer-reviewed-fulltext-article-DMSO

Similar Items